As part of its regular portfolio review, BASF is refocusing its plant biotechnology research portfolio and will restructure its Plant Science operations. The company will adjust the site footprint of its plant biotechnology research and development network in North America and Europe and intends to reduce approximately 350 positions, thereof 140 positions in North America and 180 in Europe. Currently approximately 700 employees work in plant biotechnology R&D.
Research and field sites in Research Triangle Park, North Carolina; Ames, Iowa; Berlin and Limburgerhof, Germany; Ghent, Belgium; and Brazil will be kept but are planned to be reduced in size. The field testing sites in Kekaha, Hawaii, as well as the sites in India and Puerto Rico will be closed. The restructuring is expected to be completed by the end of 2016.
Company Name | CMP |
---|---|
UPL | 485.25 |
BASF India | 3637.45 |
PI Industries | 3720.20 |
Bayer CropScience | 5754.10 |
Sumitomo Chemical India | 409.00 |
View more.. |